Furthermore, WBP2 status was positively associated with higher pathological stages and poorer survival in human glioma, gastric and non-small cell lung carcinoma (NSCLC) patients [25,71,72] (Figure 3B). This evidence concerns the gene WBP2 and non-small cell lung carcinoma.